
A hold is a decision to stay at your current dose for a while, instead of making the next reduction on the day the schedule says to make it. Nothing else changes. You take the same amount, at the same times, until your nervous system settles.
Every taper is a series of small steps down, and every step asks the brain to get by with a little less gamma-aminobutyric acid (GABA) support than it had the day before. Most steps are followed by a few rough days, and then the rough days fade. A hold is what happens when they do not fade on time.
So, is a hold a setback, or is it part of the taper? The answer shapes how a person feels about the months ahead, so it is worth getting right.
People in a taper often apologize for a hold, as if they had missed a homework deadline. They have been at the same dose for six weeks, and they feel they have fallen behind. Behind what? There is no homework, and there is no deadline.
The guilt usually comes from a frame the patient did not choose. Addiction treatment teaches that staying on a drug longer is a weakness, and that the goal is to be off of it as fast as possible. Yet, physical dependence is not addiction, and that frame does not fit a person who took a prescribed medication exactly as directed.
Dependence means the brain has adapted to the drug and needs time to adapt to its absence. Time is the treatment. A hold gives the brain more of it, which is the opposite of failing.
Professor C. Heather Ashton wrote the Ashton Manual after running a benzodiazepine withdrawal clinic for many years, and it is still the reference many benzo-aware doctors reach for first. It is free to read at benzo.org.uk. Chapter II, on how to withdraw from benzodiazepines after long-term use, presents its schedules as guides rather than rules, each one to be tailored to the individual, and it says plainly that the precise rate of withdrawal is an individual matter.
Professor Ashton was direct about pauses. If circumstances change or you hit a bad patch, the Manual says, you can stand still at a stage in your schedule and take a vacation from further withdrawal for a few weeks, and you should not let your doctor impose a deadline for finishing. What she cautioned against was going backwards up the dose, not standing still.
In fact, the Manual tells the person tapering to stay in control of their own schedule. That is how Dr. Leeds’ practice works, too. The doctor advises, prescribes, and watches for trouble, and the patient decides when they are ready for the next step.
The Maudsley Deprescribing Guidelines arrive at the same place from the receptor end. Because the relationship between dose and effect at the GABA receptor is a curve rather than a straight line, the Guidelines recommend hyperbolic reductions, meaning each cut is a proportion of the current dose, so the steps get smaller as the dose gets lower.
And, the Guidelines make the order of events explicit. You make a reduction, you wait until the symptoms from that reduction have settled, and only then do you make the next one. If the symptoms do not settle, the step was too large or too soon, and the answer is to wait longer or make the next step smaller.
The 2020 United States Food and Drug Administration (FDA) label update for all benzodiazepines says much the same thing in plainer language. If withdrawal reactions appear during a taper, the label tells prescribers to consider pausing the taper, or returning to the previous dose, and then going more slowly. That is a hold, written into the drug’s own prescribing information.
The most common reason is a wave that does not settle. A few bad days after a reduction are expected, and they are not usually a reason to hold. When the bad days stretch into two or three weeks with no sign of easing, the reduction has outrun the nervous system, and it is time to stop cutting until it catches up.
Life events are the second reason. A death in the family, a move, a divorce, a new job, or a child in trouble all load the same stress system that the taper is already straining. It is usually wiser to hold through a hard month than to try to absorb a dose reduction and a crisis at the same time.
Illness is the third. A bad flu, a surgery, a course of antibiotics, or a hormonal shift can change how a person tolerates the dose they are on, and a hold gives the body one thing to deal with instead of two. Symptoms are information. When they spike, the sensible response is to listen, not to push through and prove something. A hold is only one of several ways to get past a stuck point in a dose reduction, and it is usually the first one to try.
No. A hold means staying where you are. Going back up, sometimes called updosing, means returning to a previous, higher dose, and it is a separate decision with its own tradeoffs.
Professor Ashton advised against it. The Manual says that, as far as possible, you should never go backwards, and that you should try to avoid ever increasing the dose again. The FDA label allows it. Going backwards can leave a person parked at the higher dose and can shake confidence in the taper, so a hold is usually the first move, and a small step back is a separate option, decided together case by case and never by reflex.
What a hold is not, above all, is a reason to stop taking the medication. Stopping a benzodiazepine abruptly after continued use can cause withdrawal reactions, including seizures, which can be life-threatening. If you ever have a seizure or a severe reaction, call 911 or go to the nearest emergency room, and if you have thoughts of harming yourself, call or text 988, the Suicide and Crisis Lifeline.
Long enough, and no longer. Many holds run a few weeks, the span Professor Ashton wrote of. Some run a month or two, and a few run longer when a life event or an illness is behind them. There is no standard length, because the hold ends when the patient feels stable, not when a calendar says so.
Stable does not mean symptom-free. It means the symptoms have flattened out into something predictable that you can live with, sleep is roughly what it was before the last cut, and the fear has come down. That first stage of tolerability is the signal that the nervous system has caught up, and only then is the next step on the table.
Holds are one reason a benzodiazepine taper takes as long as it takes, and why an honest answer is measured in months to years. Unfortunately, a fixed program has a different idea of a hold. A fourteen-day facility taper does have one built in. It is called the discharge date.
Imagine walking into a cold lake in early summer. You go in to your ankles, and you stop, because it is a shock. After a minute the shock fades, you go in to your knees, and you stop again. Nobody wades in on a stopwatch.
The water did not get warmer while you stood there. You got used to it. That is what a hold does. The dose does not change, the brain changes, and when the shock has faded you take the next step down. While this is not a perfect analogy, it captures the one rule that matters: you go deeper when the last step stops being a shock, not before.
And, if a cold wind comes up while you are standing knee deep, you wait for it to pass. You do not lunge for the deep end to get it over with. Faster is not stronger. It is only faster.
Fortunately, a hold is not a hard decision when the taper is set up to expect one. Dr. Leeds sees each patient by video every week, often for up to an hour, and a good part of that visit is comparing this week to last week: sleep, appetite, the internal vibrations, the morning adrenaline surges, and the ability to work and do ordinary things. Between visits, patients can text him, day or night, when something urgent changes.
The rule of thumb is simple. If the taper rate is too fast, Dr. Leeds must advise a slower taper or a hold, and the patient decides whether to take that advice. If the taper is going well, patient and doctor may agree to take the next step, as tolerated. The brake belongs to the doctor, and the accelerator belongs to the patient. That is what a patient-directed approach to dose adjustment looks like in practice.
Patients sometimes worry that asking for a hold will make their doctor think they are not serious. The opposite is true. A patient who notices a wave early and says so is doing exactly what a patient-directed taper asks, and the plan is adjusted with them, never at them. Your doctor wants to hear from you, so do not worry about being a nuisance.
On paper, yes. In practice, a hold usually prevents the kind of destabilization that forces a much longer stop later, or a failed attempt that has to be started over. Repeated withdrawal episodes, such as failed rapid tapers, can make later withdrawal harder, a pattern called kindling, and in Dr. Leeds’ view a well-timed hold is the cheapest insurance against it.
It can. A hold that continues for months after symptoms have settled, with no illness or life event behind it, is usually fear of the next step rather than a need for more time. That fear is understandable, and it is worth talking through with your doctor rather than waiting out alone, because a smaller next step often answers it.
They are built into it. When Dr. Leeds moves a patient from a short-acting benzodiazepine to diazepam, following the Ashton Manual’s crossover taper, the switch is made one dose at a time, and the Manual’s schedules space the stages a week or two apart. Dr. Leeds gives each stage time to settle before the next change. The same principle applies to a z-drug such as zolpidem (Ambien), which acts by the same mechanism as a benzodiazepine and is tapered the same way.
Dr. Leeds is an osteopathic physician and deprescribing specialist in Fort Lauderdale, Florida, and he serves on the medical advisory board of the Benzodiazepine Information Coalition (BIC). His practice is concierge, one physician, by telemedicine for patients throughout Florida, and it is built around medically supervised benzodiazepine tapering with liquid compounded formulations, weekly video visits, and a hold whenever the nervous system asks for one. If you are tapering and are not sure whether it is time to pause, Contact the office to talk it through.
This article is educational. It is not medical advice, and reading it does not create a doctor-patient relationship. Decisions about starting, continuing, or tapering any medication should be made with your own physician.

Mark Leeds, D.O. is an osteopathic physician and deprescribing specialist in Fort Lauderdale, Florida. He helps patients come off benzodiazepines and sleeping pills with a slow, patient-directed taper guided by the Ashton Manual and the Maudsley Deprescribing Guidelines. Physical dependence is not addiction, and a careful taper is measured in months, not days.
Contact the office today to ask about a slow, medically supervised benzodiazepine taper.





